SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

CORAL LABORATORIES

BSE: 524506 09 Sep 2025
Healthcare
₹ 481
Coral Laboratories Ltd. specializes in Pharmaceuticals within the Healthcare sector.

CORAL LABORATORIES - Share Price & Details

Market Cap
₹183.0
High /Low
999.0 / 443.0
Stock P/E
9.93
Book Value
₹563.0
Dividend Yield
0.3
ROCE
17.4
ROE
₹13.1
Face Value
10.0
PEG Ratio
0.23
EVEBITDA
₹3.91
Debt
3.56
CMP / FCF
5,031
Debt to equity
₹0.02
NP Ann
24.2
High price all time
1,190
Piotroski score
₹7.0
Graham Number
797.0
No. Eq. Shares
0.36
Net CF
₹1.33
Net profit
17.9
Price to book value
0.92
Interest Coverage
₹195.0
Low price all time
23.3
Industry PE
33.1
Reserves
₹198
Free Cash Flow
₹-4.16

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.4691.0
Triochem Products Ltd.,NANANANA0
CORAL LABORATORIES LTD.NANANANA183.09.93
BDH INDUSTRIES LTD.NANANANA17918.7
KIMIA BIOSCIENCES LIMITEDNANANANA17620.1

Peer Comparison Chart


About CORAL LABORATORIES

Coral Laboratories Ltd., with Security Code 524506, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Coral Laboratories Faces Ongoing Financial Struggles Amid Declining Stock Performance

(28 Aug 2025)
Coral Laboratories has reached a new 52-week low, continuing a downward trend with a significant decline over the past year. The company faces challenges,...
Read more →

Coral Laboratories Hits New Low Amid Broader Market Downturn and Financial Struggles

(26 Aug 2025)
Coral Laboratories has reached a new 52-week low amid a broader market decline, with the Sensex also falling. The company has faced significant challenges...
Read more →

Coral Laboratories Faces Continued Decline Amidst Poor Financial Performance and Volatility

(22 Aug 2025)
Coral Laboratories, a microcap in the Pharmaceuticals & Biotechnology sector, has hit a new 52-week low, continuing a downward trend. Over the past year,...
Read more →

Coral Laboratories Faces Financial Struggles Amid Significant Stock Decline and Low Profitability

(19 Aug 2025)
Coral Laboratories has faced significant volatility, reaching a new 52-week low and continuing a downward trend. The company reported a...
Read more →

Coral Laboratories to convene board meeting

(19 Aug 2025)
Coral Laboratories will hold a meeting of the Board of Directors of the Company on 13 August 2025.
Read more →

Coral Laboratories Hits 52-Week Low Amidst Declining Sales and Profitability Challenges

(18 Aug 2025)
Coral Laboratories, a microcap in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low, reflecting a significant decline in performance...
Read more →

Company Updates